The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin

<p>Abstract</p> <p>Background</p> <p>Recent studies of CH-C patients have demonstrated a strong association between IL28B CC genotype and sustained virologic response (SVR) after PEG-IFN/RBV treatment. We aimed to assess whether IL28B alleles rs12979860 genotype influen...

Full description

Bibliographic Details
Main Authors:	Younossi Zobair M, Birerdinc Aybike, Estep Mike, Stepanova Maria, Afendy Arian, Baranova Ancha
Format:	Article
Language:	English
Published:	BMC 2012-02-01
Series:	Journal of Translational Medicine
Subjects:	HCV Gene Expression Pathway Analysis IL28B SOCS1 IRF2 chronic hepatitis C HCV treatment
Online Access:	http://www.translational-medicine.com/content/10/1/25

Similar Items

Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis
by: Amira Youssef Shaala, et al.
Published: (2015-09-01)

PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON ALPHA (PEG-IFN α) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE 1.
by: Krasimir Antonov, et al.
Published: (2011-12-01)

Replication of hepatitis C virus in peripheral blood mononuclear cells in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
by: Malgorzata Inglot, et al.
Published: (2013-03-01)

Efficacy Of Pegylated Interferon And Ribavirin Treatment In Coinfected HIV HCV Patients
by: Dumitru Irina Magdalena, et al.
Published: (2017-02-01)

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients
by: Kamil Grubczak, et al.
Published: (2021-07-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection
by: Ta-Ya Lin, et al.
Published: (2017-06-01)

Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy
by: Hafsa Aziz, et al.
Published: (2015-01-01)

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals
by: Vogel M, et al.
Published: (2010-03-01)

Molecular Biology of Hepatitis C Virus: Interactions with the IFN-Betta Signalling Pathway
by: M Sabourighannad, et al.
Published: (2005-03-01)

Molecular Biology of Hepatitis C Virus: Interactions with the IFN-Betta Signalling Pathway
by: M Sabourighannad, et al.
Published: (2005-10-01)

TYPE I INTERFERON REGULATES THE EXPRESSION OF LONG NONCODING RNAs
by: Elena eCarnero, et al.
Published: (2014-11-01)

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection
by: Mario Peribañez-Gonzalez, et al.
Published: (2013-03-01)

Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin
by: Osamu Yokosuka, et al.
Published: (2012-08-01)

The Effect of Silibinin on the Expression of TLR7, ISG15, and SOCS1 in Peripheral Blood Mononuclear Cells of Hepatitis C Infected Patients in Comparison with Interferon-α
by: Razieh Dowran, et al.
Published: (2021-03-01)

Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
by: Coppola Nicola, et al.
Published: (2012-12-01)

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV–HCV co-infected patients: final results of the Spanish BOC HIV–HCV Study
by: M. Laguno, et al.
Published: (2016-12-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

Polymorphism of Interleukin 28 and HCV: Implementation of a method
by: Alessandra Flaminio, et al.
Published: (2012-12-01)

Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-Two case reports
by: Vinod S. Hegade, M.D. MRCP, et al.
Published: (2013-07-01)

Hematological Side Effects During Combination Therapy With Interferon and Ribavirin In Chronic Hepatitis C
by: Komal Owais
Published: (2015-06-01)

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman
by: Hamid Hasson, et al.
Published: (2014-12-01)

Response factors to pegylated interferon-alfa/ribavirin treatment in chronic hepatitis C patients genotype 1b
by: Jovanović-Ćupić Snežana, et al.
Published: (2014-01-01)

Pegylated interferon, ribavirin, and frequent supportive therapy with growth factors. Which pathogenesis for a severe psoriasis complicating the treatment of chronic HCV hepatitis?
by: Roberto Manfredi
Published: (2009-12-01)

Predictors of chronic liver disease in individuals with human immunodeficiency virus infection
by: Nila Rafiq, et al.
Published: (2014-01-01)

Persistent Innate Immune Stimulation Results in IRF3-Mediated but Caspase-Independent Cytostasis
by: Christian Urban, et al.
Published: (2020-06-01)

Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon – Ribavirin in daily practice
by: Ezequiel Ridruejo, MD., et al.
Published: (2010-01-01)

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
by: Ghada M. Salum, et al.
Published: (2020-09-01)

Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
by: Tarciana Grandi, et al.
Published: (2013-02-01)

Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene
by: Tarciana Grandi, et al.
Published: (2013-02-01)

Hepatitis C virus quantification in serum and saliva of HCV-infected patients
by: Gisele Barreto Lopes Menezes, et al.
Published: (2012-08-01)

HOST FACTOR REGULATION OF HEPATITIS C VIRUS REPLICATION IN RODENT CELLS
by: Lin, Liang-Tzung
Published: (2010)

Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
by: Jiménez-Sousa María A, et al.
Published: (2013-01-01)

Feasibility of anti-HCV reflex HCV Ag screening strategy in an HCV endemic community
by: Wei-Ming Chen, et al.
Published: (2021-05-01)

Association of SNPs In Interferon Receptor Genes in Chronic Hepatitis C with Response to Combined Therapy of Interferon and Ribavirin
by: Zohreh Heidari, et al.
Published: (2014-10-01)

Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example.
by: Sandra Page, et al.
Published: (2013-01-01)

Treatment Efficacy of Sofosbuvir and Ribavirin Combination at Two Weeks in Chronic Hepatitis C
by: Aqsa Naseer
Published: (2017-12-01)

Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico
by: Aurelio López-Colombo, et al.
Published: (2014-11-01)

Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin
by: Alejandro Soza, M.D., et al.
Published: (2015-01-01)